|
|
||||||||||
|
J Am Coll Cardiol, 2003; 41:1364-1372, doi:10.1016/S0735-1097(03)00163-3 © 2003 by the American College of Cardiology Foundation |
,*



* Renal Section, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania, USA
Renal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Medicine Service, Veterans Affairs Medical Center, San Francisco, California, USA
Departments of Medicine, Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA
|| Department of Biostatistics, University of Washington, Seattle, Washington, USA
¶ Section of Nephrology, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA
# Division of Cardiology, St. Francis Hospital, Roslyn, New York, USA
** Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA

Division of Geriatric Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA
Manuscript received May 20, 2002; revised manuscript received December 4, 2002, accepted December 30, 2002.
* Reprint requests and correspondence: Dr. Linda F. Fried, VA Pittsburgh Healthcare System, 111F-U, University Drive C, Pittsburgh, Pennsylvania 15240, USA.
lff9+{at}pitt.edu
OBJECTIVES: This study was designed to evaluate the relationship between elevated creatinine levels and cardiovascular events.
BACKGROUND: End-stage renal disease is associated with high cardiovascular morbidity and mortality. The association of mild to moderate renal insufficiency with cardiovascular outcomes remains unclear.
METHODS: We analyzed data from the Cardiovascular Health Study, a prospective population-based study of subjects, aged >65 years, who had a serum creatinine measured at baseline (n = 5,808) and were followed for a median of 7.3 years. Proportional hazards models were used to examine the association of creatinine to all-cause mortality and incident cardiovascular mortality and morbidity. Renal insufficiency was defined as a creatinine level
1.5 mg/dl in men or
1.3 mg/dl in women.
RESULTS: An elevated creatinine level was present in 648 (11.2%) participants. Subjects with elevated creatinine had higher overall (76.7 vs. 29.5/1,000 years, p < 0.001) and cardiovascular (35.8 vs. 13.0/1,000 years, p < 0.001) mortality than those with normal creatinine levels. They were more likely to develop cardiovascular disease (54.0 vs. 31.8/1,000 years, p < 0.001), stroke (21.1 vs. 11.9/1,000 years, p < 0.001), congestive heart failure (38.7 vs. 17/1,000 years, p < 0.001), and symptomatic peripheral vascular disease (10.6 vs. 3.5/1,000 years, p < 0.001). After adjusting for cardiovascular risk factors and subclinical disease measures, elevated creatinine remained a significant predictor of all-cause and cardiovascular mortality, total cardiovascular disease (CVD), claudication, and congestive heart failure (CHF). A linear increase in risk was observed with increasing creatinine.
CONCLUSIONS: Elevated creatinine levels are common in older adults and are associated with increased risk of mortality, CVD, and CHF. The increased risk is apparent early in renal disease.
| ||||||||||||||||||||||||
This article has been cited by other articles:
![]() |
Y. P. Liew, J. R. Bartholomew, S. Demirjian, J. Michaels, and M. J. Schreiber Jr. Combined Effect of Chronic Kidney Disease and Peripheral Arterial Disease on All-Cause Mortality in a High-Risk Population Clin. J. Am. Soc. Nephrol., July 1, 2008; 3(4): 1084 - 1089. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Harper and T. A. Jacobson Managing dyslipidemia in chronic kidney disease. J. Am. Coll. Cardiol., June 24, 2008; 51(25): 2375 - 2384. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Schocken, E. J. Benjamin, G. C. Fonarow, H. M. Krumholz, D. Levy, G. A. Mensah, J. Narula, E. S. Shor, J. B. Young, and Y. Hong Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, May 13, 2008; 117(19): 2544 - 2565. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Cirillo, M. P. Lanti, A. Menotti, M. Laurenzi, M. Mancini, A. Zanchetti, and N. G. De Santo Definition of Kidney Dysfunction as a Cardiovascular Risk Factor: Use of Urinary Albumin Excretion and Estimated Glomerular Filtration Rate Arch Intern Med, March 24, 2008; 168(6): 617 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF] |
||||
![]() |
D. Pereg, A. Tirosh, T. Shochat, D. Hasdai, and for the Metabolic, Lifestyle and Nutrition Assessm Mild renal dysfunction associated with incident coronary artery disease in young males Eur. Heart J., January 2, 2008; 29(2): 198 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Brugts, E. Boersma, M. Chonchol, J. W. Deckers, M. Bertrand, W. J. Remme, R. Ferrari, K. Fox, M. L. Simoons, and on behalf of the EUROPA Investigators The Cardioprotective Effects of the Angiotensin-Converting Enzyme Inhibitor Perindopril in Patients With Stable Coronary Artery Disease Are Not Modified by Mild to Moderate Renal Insufficiency: Insights From the EUROPA Trial J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2148 - 2155. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshida, H. Tomiyama, J. Yamada, Y. Koji, K. Shiina, M. Nagata, and A. Yamashina Relationships among Renal Function Loss within the Normal to Mildly Impaired Range, Arterial Stiffness, Inflammation, and Oxidative Stress Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1118 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Corriere and K. J. Hansen Commentary on "The Role of Embolic Protection Devices in Renal Artery Stenting" Perspectives in Vascular Surgery and Endovascular Therapy, September 1, 2007; 19(3): 272 - 274. [PDF] |
||||
![]() |
R. N. Foley, C. Wang, A. Ishani, and A. J. Collins NHANES III: Influence of Race on GFR Thresholds and Detection of Metabolic Abnormalities J. Am. Soc. Nephrol., September 1, 2007; 18(9): 2575 - 2582. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Wannamethee, P. H. Whincup, L. Lennon, and N. Sattar Circulating Adiponectin Levels and Mortality in Elderly Men With and Without Cardiovascular Disease and Heart Failure Arch Intern Med, July 23, 2007; 167(14): 1510 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Foster, S.-J. Hwang, M. G. Larson, N. I. Parikh, J. B. Meigs, R. S. Vasan, T. J. Wang, D. Levy, and C. S. Fox Cross-Classification of Microalbuminuria and Reduced Glomerular Filtration Rate: Associations Between Cardiovascular Disease Risk Factors and Clinical Outcomes Arch Intern Med, July 9, 2007; 167(13): 1386 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Menon, M. G. Shlipak, X. Wang, J. Coresh, T. Greene, L. Stevens, J. W. Kusek, G. J. Beck, A. J. Collins, A. S. Levey, et al. Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease Ann Intern Med, July 3, 2007; 147(1): 19 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ingelsson, J. Sundstrom, L. Lind, U. Riserus, A. Larsson, S. Basu, and J. Arnlov Low-grade albuminuria and the incidence of heart failure in a community-based cohort of elderly men Eur. Heart J., July 2, 2007; 28(14): 1739 - 1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A.A. Fox, E. M. Antman, G. Montalescot, S. Agewall, B. SomaRaju, F. W.A. Verheugt, J. Lopez-Sendon, H. Hod, S. A. Murphy, and E. Braunwald The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial J. Am. Coll. Cardiol., June 12, 2007; 49(23): 2249 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kottgen, S. D. Russell, L. R. Loehr, C. M. Crainiceanu, W. D. Rosamond, P. P. Chang, L. E. Chambless, and J. Coresh Reduced Kidney Function as a Risk Factor for Incident Heart Failure: The Atherosclerosis Risk in Communities (ARIC) Study J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1307 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Hemmelgarn, B. J. Manns, J. Zhang, M. Tonelli, S. Klarenbach, M. Walsh, B. F. Culleton, and for the Alberta Kidney Disease Network Association between Multidisciplinary Care and Survival for Elderly Patients with Chronic Kidney Disease J. Am. Soc. Nephrol., March 1, 2007; 18(3): 993 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Van Biesen, D. De Bacquer, F. Verbeke, J. Delanghe, N. Lameire, and R. Vanholder The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years Eur. Heart J., February 2, 2007; 28(4): 478 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wattanakit, A. R. Folsom, E. Selvin, J. Coresh, A. T. Hirsch, and B. D. Weatherley Kidney Function and Risk of Peripheral Arterial Disease: Results from the Atherosclerosis Risk in Communities (ARIC) Study J. Am. Soc. Nephrol., February 1, 2007; 18(2): 629 - 636. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ingelsson, K. Bjorklund-Bodegard, L. Lind, J. Arnlov, and J. Sundstrom Congestive Heart Failure and Diurnal Blood Pressure Pattern--Reply JAMA, December 20, 2006; 296(23): 2800 - 2800. [Full Text] [PDF] |
||||
![]() |
S. G. Wannamethee, A. G. Shaper, G. D.O. Lowe, L. Lennon, A. Rumley, and P. H. Whincup Renal function and cardiovascular mortality in elderly men: the role of inflammatory, procoagulant, and endothelial biomarkers Eur. Heart J., December 2, 2006; 27(24): 2975 - 2981. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.C. Edwards, R.P. Steeds, C.J. Ferro, and J.N. Townend The treatment of coronary artery disease in patients with chronic kidney disease QJM, November 1, 2006; 99(11): 723 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wattanakit, J. Coresh, P. Muntner, J. Marsh, and A. R. Folsom Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction J. Am. Coll. Cardiol., September 19, 2006; 48(6): 1183 - 1189. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. McCullough, M. E. Bertrand, J. A. Brinker, and F. Stacul A Meta-Analysis of the Renal Safety of Isosmolar Iodixanol Compared With Low-Osmolar Contrast Media J. Am. Coll. Cardiol., August 15, 2006; 48(4): 692 - 699. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Walker, G. Schneider, J. Yeaw, B. Nordstrom, S. Robbins, and D. Pettitt Anemia as a Predictor of Cardiovascular Events in Patients with Elevated Serum Creatinine J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2293 - 2298. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Koren-Morag, U. Goldbourt, and D. Tanne Renal dysfunction and risk of ischemic stroke or TIA in patients with cardiovascular disease. Neurology, July 25, 2006; 67(2): 224 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ponikowski Rationale and design of CIBIS III Eur. Heart J. Suppl., June 1, 2006; 8(suppl_C): C35 - C42. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Hemmelgarn, D. A. Southern, K. H. Humphries, B. F. Culleton, M. L. Knudtson, W. A. Ghali, and for the Alberta Provincial Project for Outcomes As Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterization Eur. Heart J., May 2, 2006; 27(10): 1191 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. T. Bloomgarden Insulin Treatment and Type 1 Diabetes Topics Diabetes Care, April 1, 2006; 29(4): 936 - 944. [Full Text] [PDF] |
||||
![]() |
R. E. Gilbert, K. Connelly, D. J. Kelly, C. A. Pollock, and H. Krum Heart Failure and Nephropathy: Catastrophic and Interrelated Complications of Diabetes Clin. J. Am. Soc. Nephrol., March 1, 2006; 1(2): 193 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. O'Hare, D. Bertenthal, K. E. Covinsky, C. S. Landefeld, S. Sen, K. Mehta, M. A. Steinman, A. Borzecki, and L. C. Walter Mortality Risk Stratification in Chronic Kidney Disease: One Size for All Ages? J. Am. Soc. Nephrol., March 1, 2006; 17(3): 846 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Maaravi, M. Bursztyn, R. Hammerman-Rozenberg, A. Cohen, and J. Stessman Moderate renal insufficiency at 70 years predicts mortality QJM, February 1, 2006; 99(2): 97 - 102. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stam, C. van Guldener, A. Becker, J. M. Dekker, R. J. Heine, L. M. Bouter, and C. D.A. Stehouwer Endothelial Dysfunction Contributes to Renal Function-Associated Cardiovascular Mortality in a Population with Mild Renal Insufficiency: The Hoorn Study J. Am. Soc. Nephrol., February 1, 2006; 17(2): 537 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Shlipak, C. L. W. Fyr, G. M. Chertow, T. B. Harris, S. B. Kritchevsky, F. A. Tylavsky, S. Satterfield, S. R. Cummings, A. B. Newman, and L. F. Fried Cystatin C and Mortality Risk in the Elderly: The Health, Aging, and Body Composition Study J. Am. Soc. Nephrol., January 1, 2006; 17(1): 254 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Leeder, P. Mitchell, G. Liew, E. Rochtchina, W. Smith, and J. J. Wang Low Hemoglobin, Chronic Kidney Disease, and Risk for Coronary Heart Disease-Related Death: The Blue Mountains Eye Study J. Am. Soc. Nephrol., January 1, 2006; 17(1): 279 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Brugts, A. M. Knetsch, F. U. S. Mattace-Raso, A. Hofman, and J. C. M. Witteman Renal Function and Risk of Myocardial Infarction in an Elderly Population: The Rotterdam Study Arch Intern Med, December 12, 2005; 165(22): 2659 - 2665. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. O'Hare, A. B. Newman, R. Katz, L. F. Fried, C. O. Stehman-Breen, S. L. Seliger, D. S. Siscovick, and M. G. Shlipak Cystatin C and Incident Peripheral Arterial Disease Events in the Elderly: Results From the Cardiovascular Health Study Arch Intern Med, December 12, 2005; 165(22): 2666 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Seliger, W.T. Longstreth Jr, R. Katz, T. Manolio, L. F. Fried, M. Shlipak, C. O. Stehman-Breen, A. Newman, M. Sarnak, D. L. Gillen, et al. Cystatin C and Subclinical Brain Infarction J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3721 - 3727. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Fried, R. Katz, M. J. Sarnak, M. G. Shlipak, P. H.M. Chaves, N. S. Jenny, C. Stehman-Breen, D. Gillen, A. J. Bleyer, C. Hirsch, et al. Kidney Function as a Predictor of Noncardiovascular Mortality J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3728 - 3735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shlipak and C. Stehman-Breen Observational Research Databases in Renal Disease J. Am. Soc. Nephrol., December 1, 2005; 16(12): 3477 - 3484. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Fox, M. G. Larson, E. P. Leip, J. B. Meigs, P. W.F. Wilson, and D. Levy Glycemic Status and Development of Kidney Disease: The Framingham Heart Study Diabetes Care, October 1, 2005; 28(10): 2436 - 2440. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Gil, S. Justo, and C. Caramelo Cardio-renal failure: an emerging clinical entity Nephrol. Dial. Transplant., September 1, 2005; 20(9): 1780 - 1783. [Full Text] [PDF] |
||||
![]() |
A. M. O'Hare, R. A. Rodriguez, and P. Bacchetti Low Ankle-Brachial Index Associated With Rise in Creatinine Level Over Time: Results From the Atherosclerosis Risk in Communities Study Arch Intern Med, July 11, 2005; 165(13): 1481 - 1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vanholder, Z. Massy, A. Argiles, G. Spasovski, F. Verbeke, N. Lameire, and for the European Uremic Toxin Work Group (EUTox) Chronic kidney disease as cause of cardiovascular morbidity and mortality Nephrol. Dial. Transplant., June 1, 2005; 20(6): 1048 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Shlipak, M. J. Sarnak, R. Katz, L. F. Fried, S. L. Seliger, A. B. Newman, D. S. Siscovick, and C. Stehman-Breen Cystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons N. Engl. J. Med., May 19, 2005; 352(20): 2049 - 2060. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Sarnak, R. Katz, C. O. Stehman-Breen, L. F. Fried, N. S. Jenny, B. M. Psaty, A. B. Newman, D. Siscovick, M. G. Shlipak, and and the Cardiovascular Health Study* Cystatin C Concentration as a Risk Factor for Heart Failure in Older Adults Ann Intern Med, April 5, 2005; 142(7): 497 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Smith, M. G. Shlipak, E. P. Havranek, F. A. Masoudi, W. M. McClellan, J. M. Foody, S. S. Rathore, and H. M. Krumholz Race and Renal Impairment in Heart Failure: Mortality in Blacks Versus Whites Circulation, March 15, 2005; 111(10): 1270 - 1277. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M.A. van de Wal, B. L. van Brussel, A. A. Voors, T. D.J. Smilde, J. C. Kelder, H. A. van Swieten, W. H. van Gilst, D. J. van Veldhuisen, and H.W. T. Plokker Mild preoperative renal dysfunction as a predictor of long-term clinical outcome after coronary bypass surgery J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 330 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Foley, A. M. Murray, S. Li, C. A. Herzog, A. M. McBean, P. W. Eggers, and A. J. Collins Chronic Kidney Disease and the Risk for Cardiovascular Disease, Renal Replacement, and Death in the United States Medicare Population, 1998 to 1999 J. Am. Soc. Nephrol., February 1, 2005; 16(2): 489 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Muntner, J. He, B. C. Astor, A. R. Folsom, and J. Coresh Traditional and Nontraditional Risk Factors Predict Coronary Heart Disease in Chronic Kidney Disease: Results from the Atherosclerosis Risk in Communities Study J. Am. Soc. Nephrol., February 1, 2005; 16(2): 529 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Koenig, D. Twardella, H. Brenner, and D. Rothenbacher Plasma Concentrations of Cystatin C in Patients with Coronary Heart Disease and Risk for Secondary Cardiovascular Events: More than Simply a Marker of Glomerular Filtration Rate Clin. Chem., February 1, 2005; 51(2): 321 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Edwards, T. E. Craven, G. L. Burke, R. H. Dean, and K. J. Hansen Renovascular Disease and the Risk of Adverse Coronary Events in the Elderly: A Prospective, Population-Based Study Arch Intern Med, January 24, 2005; 165(2): 207 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Bongartz, M. J. Cramer, P. A. Doevendans, J. A. Joles, and B. Braam The severe cardiorenal syndrome: 'Guyton revisited' Eur. Heart J., January 1, 2005; 26(1): 11 - 17. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Jaff Expert Commentary Perspectives in Vascular Surgery and Endovascular Therapy, December 1, 2004; 16(4): 258 - 260. [PDF] |
||||
![]() |
L. Fried, C. Solomon, M. Shlipak, S. Seliger, C. Stehman-Breen, A. J. Bleyer, P. Chaves, C. Furberg, L. Kuller, and A. Newman Inflammatory and Prothrombotic Markers and the Progression of Renal Disease in Elderly Individuals J. Am. Soc. Nephrol., December 1, 2004; 15(12): 3184 - 3191. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Shlipak, G. L. Smith, S. S. Rathore, B. M. Massie, and H. M. Krumholz Renal Function, Digoxin Therapy, and Heart Failure Outcomes: Evidence from the Digoxin Intervention Group Trial J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2195 - 2203. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. O'Hare, E. Vittinghoff, J. Hsia, and M. G. Shlipak Renal Insufficiency and the Risk of Lower Extremity Peripheral Arterial Disease: Results from the Heart and Estrogen/Progestin Replacement Study (HERS) J. Am. Soc. Nephrol., April 1, 2004; 15(4): 1046 - 1051. [Abstract] [Full Text] [PDF] |
||||